Professor
Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (UiO), Oslo, Norway
Oslo, Norway
Hedvig Nordeng, M.ScPharm, Dr.philos. is a professor and head of the Pharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo (Ui0), Norway. Professor Nordeng’s research experience and expertise lies within perinatal pharmacoepidemiology and pharmacotherapy during pregnancy and breast feeding.
She has a long track record of interdisciplinary research and of international research projects, using large population-based cohorts and linked health care registries, especially in the Nordic countries. She was awarded an ERC StG for the project “DrugsInPregnancy” and is currently the head of an International Partnerships for Excellent Education, Research and Innovation on genetic pharmacoepidemiology (iAPOGEE) and head of the UiOLifeScience convergence environment UIORealArt: Real world – artificial worlds: Improving causal inference in perinatal pharmaco-epidemiology using machine learning approaches on real-world and artificial data. Over the past years, she has put great efforts into creating a data analytical pipeline at the University of Oslo for rapid analysis of urgent perinatal pharmacovigilance signals.
Dr. Nordeng is the editor of a textbook in clinical pharmacology for nurses and has authored over 200 scientific articles, book chapters and clinical guidelines, many of which focus on perinatal drug use and safety. In 2023, she was awarded the Women's Research Award from the Norwegian Women's Public Health Association, Norway's largest women's organization, for her research to improve women’s health.
As of 2018, she has been an EU commission appointed independent scientific expert member of PRAC, European Medicines Agency. She is a member of NorPEN (Nordic Pharmacoepidemiology Network) and a fellow of the International Society of Pharmacoepidemiology (FISPE). As of 2024, she holds a position as adjunct Professor in Clinical Farmacology at the Faculty of Health Sciences, University of Southern Denmark.
Read more about her research here: www.mn.uio.no/farmasi/english/research/groups/pharma-safe/index.html
Disclosure information not submitted.
The Treatment and Prevention of Pregnancy-related Infections
Monday, August 26, 2024
1:30 PM – 3:00 PM CEST
Tuesday, August 27, 2024
8:00 AM – 8:15 AM CEST
Tuesday, August 27, 2024
9:15 AM – 9:30 AM CEST
Effectiveness of COVID-19 vaccines administered during pregnancy in Spain and Norway
Tuesday, August 27, 2024
8:45 AM – 9:00 AM CEST
Tuesday, August 27, 2024
10:00 AM – 11:30 AM CEST
Tuesday, August 27, 2024
1:15 PM – 1:30 PM CEST
Tuesday, August 27, 2024
2:00 PM – 2:15 PM CEST
Wednesday, August 28, 2024
8:45 AM – 9:00 AM CEST